RGEN
Repligen Corporation
Medical Instruments & Supplies · Healthcare · United States
167.49
close · 2026-08-13
value
9
cheaper than peers9
quality
50
stronger fundamentals50
ranked against
Medical Instruments & Supplies
value
quality
25 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 4.47× | 31 |
| price to sales | 10.14× | 16 |
| EV to EBITDA | 55.41× | 15 |
| forward P/E | 63.47× | 11 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 11.9% | 69 |
| debt to equity | 32.7% | 59 |
| return on equity | 2.0% | 40 |
| operating margin | 9.3% | 38 |
4 of 4 measures available
Facts
| market cap | $9B |
| free cash flow | $113.4M |
| employees | 2,000 |
| first trade | 1986-04-29 |
| next earnings | 2026-07-28 |
| fundamentals updated | 2026-07-31 |